Screening uptake of colonoscopy versus fecal immunochemical testing in first-degree relatives of patients with non-syndromic colorectal cancer: A multicenter, open-label, parallel-group, randomized trial (ParCoFit study)
In a randomized trial Natalia González-López and co-workers investigate whether fecal immunochemical testing improves screening uptake in first degree relatives of patients with non-syndromic colorectal cancer.
Source: plos.org